Summit Therapeutics Inc (SMMT)
4.955
-0.36
(-6.69%)
USD |
NASDAQ |
May 08, 16:00
4.955
0.00 (0.00%)
After-Hours: 20:00
Summit Therapeutics Max Drawdown (5Y): 95.17% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 95.17% |
March 31, 2024 | 95.17% |
February 29, 2024 | 95.17% |
January 31, 2024 | 95.17% |
December 31, 2023 | 95.17% |
November 30, 2023 | 95.17% |
October 31, 2023 | 95.17% |
September 30, 2023 | 95.17% |
August 31, 2023 | 95.17% |
July 31, 2023 | 95.17% |
June 30, 2023 | 95.17% |
May 31, 2023 | 95.17% |
April 30, 2023 | 95.17% |
March 31, 2023 | 95.17% |
February 28, 2023 | 95.17% |
January 31, 2023 | 95.17% |
December 31, 2022 | 95.17% |
November 30, 2022 | 94.32% |
October 31, 2022 | 94.23% |
September 30, 2022 | 94.23% |
August 31, 2022 | 94.23% |
July 31, 2022 | 94.23% |
June 30, 2022 | 94.23% |
May 31, 2022 | 94.23% |
April 30, 2022 | 92.81% |
Date | Value |
---|---|
March 31, 2022 | 92.81% |
February 28, 2022 | 92.81% |
January 31, 2022 | 92.81% |
December 31, 2021 | 92.81% |
November 30, 2021 | 92.81% |
October 31, 2021 | 92.81% |
September 30, 2021 | 92.81% |
August 31, 2021 | 92.81% |
July 31, 2021 | 92.81% |
June 30, 2021 | 92.81% |
May 31, 2021 | 92.81% |
April 30, 2021 | 92.81% |
March 31, 2021 | 92.81% |
February 28, 2021 | 92.81% |
January 31, 2021 | 92.81% |
December 31, 2020 | 92.81% |
November 30, 2020 | 92.81% |
October 31, 2020 | 92.81% |
September 30, 2020 | 92.81% |
August 31, 2020 | 92.81% |
July 31, 2020 | 92.81% |
June 30, 2020 | 92.81% |
May 31, 2020 | 92.81% |
April 30, 2020 | 92.81% |
March 31, 2020 | 92.81% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
92.81%
Minimum
May 2019
95.17%
Maximum
Dec 2022
93.65%
Average
92.81%
Median
May 2019
Max Drawdown (5Y) Benchmarks
Retractable Technologies Inc | 95.49% |
BioCardia Inc | 98.49% |
Alpine Immune Sciences Inc | 97.33% |
Axsome Therapeutics Inc | 81.26% |
Krystal Biotech Inc | 53.42% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 27.94 |
Beta (5Y) | -1.133 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 185.7% |
Historical Sharpe Ratio (5Y) | 0.0825 |
Historical Sortino (5Y) | 0.3116 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.60% |